SCHEMBL13664808

SCHEMBL13664808

CC(C)(C)OC(=O)N(Cc1ccccc1)CC1(CNc2ccc3ccccc3c2)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 3/20 0.43
HDAC3 O15379 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC2 Q92769 1/20 0.42
NCOR2 Q9Y618 1/20 0.42
MRGPRX4 Q96LA9 1/20 0.39
CTSL P07711 1/20 0.38
CTSB P07858 1/20 0.38
CTSS P25774 1/20 0.38
USP2 O75604 1/20 0.38
ALDH1A1 P00352 1/20 0.38
HPGD P15428 1/20 0.38
NPFFR1 Q9GZQ6 1/20 0.37
NPFFR2 Q9Y5X5 1/20 0.37
UBE2M P61081 1/20 0.37
DCUN1D1 Q96GG9 1/20 0.37
KDM4E B2RXH2 2/20 0.37
LMNA P02545 1/20 0.37
GAA P10253 1/20 0.37
HTT P42858 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13664807 0.77 ALDH1A1 (0.45) MRGPRX4USP2ALDH1A1HPGDUBE2M
SCHEMBL4367428 0.75 AKT1 (0.48) BACE1HDAC3HDAC1HDAC2NCOR2
SCHEMBL13665270 0.72 UBE2M (0.38) MRGPRX4USP2ALDH1A1HPGDUBE2M
SCHEMBL25736670 0.70 HDAC3 (0.53) BACE1HDAC3HDAC1HDAC2NCOR2
SCHEMBL7857951 0.70 PSMB5 (0.46) BACE1ALDH1A1HPGDKDM4ELMNA
SCHEMBL7405554 0.70 HDAC3 (0.55) BACE1HDAC3HDAC1HDAC2NCOR2
SCHEMBL20028119 0.69 HDAC3 (0.58) BACE1HDAC3HDAC1HDAC2NCOR2
SCHEMBL23288368 0.69 LMNA (0.60) HDAC3HDAC1HDAC2NCOR2CTSL
SCHEMBL13664693 0.68 ALDH1A1 (0.46) MRGPRX4USP2ALDH1A1HPGDKDM4E
SCHEMBL8127646 0.68 HDAC1 (0.53) BACE1HDAC3HDAC1HDAC2NCOR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009119528-A1 HETEROCYCLIC COMPOUND 武田薬品工業株式会社 (JP) 2009-10-01 WO disclosed